Delivery Order SPE2DB20D2104-SPE2DB25FNAYN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,528.86 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100 count units) with a completion deadline of June 2, 2025. This is a competitively awarded, firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,266.54 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and carries an ultimate completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order valued at $23,424.76 to AmerisourceBergen Drug Corp for Adderall 20 mg tablets (100 count) on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,165.05 to AmerisourceBergen Drug Corp for 100 tablets of Adderall 5 mg on May 13, 2025, with an ultimate completion date of May 14, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,793.21 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) with a firm fixed price and a completion deadline of August 26, 2025. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a $999.999 billion potential value through...
- The Defense Logistics Agency awarded a delivery order valued at $2,532.04 to AmerisourceBergen Drug Corp for 100 tablets of Adderall 5 mg, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The performance location is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,740.47 for Adderall 20 mg tablets (100 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,266.02 for 100 tablets of Adderall 15 mg, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order executed under AmerisourceBergen's larger pharmaceutical supply framework with the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $20K to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100 count) under a firm fixed-price contract structure. The award, issued on May 3, 2025, with an ultimate completion date of May 5, 2025, represents a competitive, non-set-aside procurement fulfilled by AmerisourceBergen's Corporate Office facility located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,939.56 to AmerisourceBergen Drug Corp for the supply of Adderall 15 mg tablets (100-count units) on September 18, 2025, with completion expected by September 19, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAYNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,064.08 to AmerisourceBergen Drug Corp for 100 tablets of Adderall 20 mg, with an ultimate completion date of September 22, 2025. This is a firm fixed-price delivery order issued under a non-competitive set-aside arrangement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's medical supply chain. This delivery order represents a drawdown against AmerisourceBergen Drug Corp's substantial indefinite delivery contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent contract functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates proven capability in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains, including neurological treatments, pain management, and specialty medications for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 9/19/25 |